{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "CLEARMIND MEDICINE INC.", "longName": "Clearmind Medicine Inc.", "messageBoardId": "finmb_546305599", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 3.3755279, "regularMarketPrice": 0.49, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.9432871, "fiftyTwoWeekLow": 0.328, "fiftyTwoWeekHigh": 8.64, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.71, "sharesOutstanding": 5587910, "bookValue": 2.075, "fiftyDayAverage": 1.67104, "fiftyDayAverageChange": -1.18104, "fiftyDayAverageChangePercent": -0.70676947, "twoHundredDayAverage": 4.132775, "twoHundredDayAverageChange": -3.6427748, "twoHundredDayAverageChangePercent": -0.8814356, "marketCap": 2982331, "priceToBook": 0.23614457, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.016000003, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.49, "regularMarketDayRange": "0.49 - 0.49", "regularMarketDayLow": 0.49, "regularMarketVolume": 903, "regularMarketPreviousClose": 0.474, "bid": 0.55, "ask": 0.67, "fullExchangeName": "Frankfurt", "financialCurrency": "CAD", "regularMarketOpen": 0.49, "averageDailyVolume3Month": 111, "averageDailyVolume10Day": 90, "fiftyTwoWeekLowChange": 0.162, "fiftyTwoWeekLowChangePercent": 0.49390242, "fiftyTwoWeekRange": "0.328 - 8.64", "fiftyTwoWeekHighChange": -8.150001, "firstTradeDateMilliseconds": 1628488800000, "symbol": "CWY.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1220 West 6th Avenue", "address2": "Suite 101", "city": "Vancouver", "state": "BC", "zip": "V6H 1A5", "country": "Canada", "phone": "604 260 1566", "website": "https://www.clearmindmedicine.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Adi  Zuloff-Shani Ph.D.", "age": 53, "title": "Chief Exec. Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alan Mark Rootenberg B.Com., B.Comm, C.A., CPA", "age": 70, "title": "Chief Financial Officer", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Mark  Haden", "age": 67, "title": "VP of Bus. Devel.", "yearBorn": 1955, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gilad  Babchuk", "title": "Head of Strategy & Communication", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}